Interaction between angiotensin-converting enzyme inhibitors and aspirin: a review C. MeuneI. MaheC. Caulin Review Article 07 November 2000 Pages: 609 - 620
Inhibition of puerperal lactation with 2-mercaptopropionyl-glycine C. AkrivisP. VezyrakiA. Evangelou Clinical Trials 08 December 2000 Pages: 621 - 623
Assessment of the systemic effects of beclomethasone dipropionate inhaled via Easyhaler or via Diskhaler in healthy male volunteers K.M. HämäläinenA. MalinenM. Silvasti Pharmacodynamics 04 November 2000 Pages: 625 - 629
Efficacy of combination of atorvastatin and micronised fenofibrate in the treatment of severe mixed hyperlipidemia D.N. KiortsisH. MillionisM.S. Elisaf Pharmacodynamics 20 October 2000 Pages: 631 - 635
Blood pressure responses to whole-body cold exposure: effect of carvedilol Silja KomulainenTuula TähtinenSirkka Keinänen-Kiukaanniemi Pharmacodynamics 20 October 2000 Pages: 637 - 642
Effects of grapefruit juice on the stereoselective disposition of nicardipine in humans: evidence for dominant presystemic elimination at the gut site T. UnoT. OhkuboT. Ishizaki Pharmacokinetics and Disposition 29 November 2000 Pages: 643 - 649
In-vivo indices of CYP2D6 activity: comparison of dextromethorphan metabolic ratios in 4-h urine and 3-h plasma J. ChládekG. ZimováJ. Martínková Pharmacokinetics and Disposition 24 November 2000 Pages: 651 - 657
Mycophenolic acid glucuronidation and its inhibition by non-steroidal anti-inflammatory drugs in human liver and kidney M. VietriA. PietrabissaG.M. Pacifici Pharmacokinetics and Disposition 01 December 2000 Pages: 659 - 664
Pharmacokinetics of esomeprazole after oral and intravenous administration of single and repeated doses to healthy subjects M. Hassan-AlinT. AndersonnK. Röhss Pharmacokinetics and Disposition 25 October 2000 Pages: 665 - 670
Influence of continuous veno–venous haemodiafiltration and continuous veno–venous haemofiltration on the pharmacokinetics of fluconazole E. MuhlT. MartensH.-P. Bruch Pharmacokinetics and Disposition 08 December 2000 Pages: 671 - 678
CYP2D6 genotype and antipsychotic-induced extrapyramidal side effects in schizophrenic patients M.G. ScordoE. SpinaF. Sjöqvist Pharmacokinetics and Disposition 08 December 2000 Pages: 679 - 683
Consideration of endogenous backgrounds in pharmacokinetic analyses: a simulation study Fritz Schindel Pharmacokinetics and Disposition 08 December 2000 Pages: 685 - 688
Correlation between acetylation phenotype and genotype in Chinese women Bin ZhaoAdeline SeowHin-Peng Lee Pharmacokinetics and Disposition 18 October 2000 Pages: 689 - 692
Effect of grapefruit juice on pharmacokinetics and pharmacodynamics of verapamil enantiomers in healthy volunteers Ping-Chuen HoKarabi GhoseSompon Wanwimolruk Pharmacokinetics and Disposition 20 October 2000 Pages: 693 - 698
Citalopram pharmacokinetics in patients with chronic renal failure and the effect of haemodialysis Olav SpigsetStaffan HäggRune Dahlqvist Pharmacokinetics and Disposition 20 October 2000 Pages: 699 - 703
Pharmacokinetic and pharmacodynamic interactions between the novel calcium sensitiser levosimendan and warfarin Saila AntilaAsko JarvinenLasse Lehtonen Pharmacokinetics and Disposition 20 October 2000 Pages: 705 - 710
Effects and pharmacokinetics of oral glibenclamide and glipizide in Caucasian and Chinese patients with type-2 diabetes Anders JönssonJuliana C.N. ChanArne Melander Pharmacokinetics and Disposition 25 October 2000 Pages: 711 - 714
Steady-state dispositions of valproate and diflunisal alone and coadministered to healthy volunteers R.S. AddisonS.L. Parker-ScottR.G. Dickinson Pharmacokinetics and Disposition 21 October 2000 Pages: 715 - 721
Different versions of the anatomical therapeutic chemical classification system and the defined daily dose – are drug utilisation data comparable? Marit RønningHege Salvesen BlixHanne Strøm Pharmacoepidemiology and Prescription 21 October 2000 Pages: 723 - 727
Attitudes to reporting adverse drug reactions in northern Sweden Martin BäckströmTom MjörndalTorborg Nordkvist-Olsson Pharmacoepidemiology and Prescription 18 October 2000 Pages: 729 - 732
Detecting drug–drug interactions using a database for spontaneous adverse drug reactions: an example with diuretics and non-steroidal anti-inflammatory drugs Eugène P. van PuijenbroekAntoine C.G. EgbertsHubert G.M. Leufkens Pharmacoepidemiology and Prescription 07 November 2000 Pages: 733 - 738
Predictors for prophylactic antithrombotic prescribing in ischaemic heart disease and the impact of national guidelines R. FijnA.G.G. Stuurman-BiezeL.T.W. de Jong-van den Berg Pharmacoepidemiology and Prescription 21 November 2000 Pages: 739 - 746
Influence of physician's education, drug information and medical-care settings on the quality of drugs prescribed Adolfo FigueirasFrancisco CaamañoJuan Jesus Gestal-Otero Pharmacokinetics and Prescription 21 November 2000 Pages: 747 - 753
A study of drug utilisation and cost of treatment in patients hospitalised with unstable angina S. MalhotraA. GroverV.K. Bhargava Pharmacokinetics and Prescription 08 December 2000 Pages: 755 - 761
Agranulocytosis associated with calcium dobesilate Luisa IbáñezElena BallarínJoan-Ramon Laporte Pharmacoepidemiology and Prescription 15 November 2000 Pages: 763 - 767
Candesartan and acute liver injury D. González-JiménezJ.M. VarelaM.A. González de la Puente Case Report 21 November 2000 Pages: 769 - 770
Prolonged sedation due to an accumulation of midazolam in an intensive care patient with hypothyroidism M. BolonO. BastienR. Boulieu Letter to the Editors 29 November 2000 Pages: 771 - 772
